ReThink Medical
ReThink Medical produces a remote patient physiologic monitor for predicting heart failure related hospitalizations.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
$3.0m | Series A | ||
| Total Funding | 000k | ||
Related Content
ReThink Medical, Inc. operated as a medical device and digital health company focused on the significant challenge of heart failure management. Founded in 2010 by Reza Naima, the San Francisco-based firm aimed to shift heart failure care from a reactive to a proactive model. The company's core mission was to predict and prevent costly and life-threatening hospitalizations by using continuous physiological monitoring and predictive analytics.
The company's flagship product under development was the CorBand™, a wrist-worn device designed for non-invasive, continuous monitoring of heart failure patients in an ambulatory setting. The CorBand™ was engineered to track key physiological parameters, which could then be streamed via Bluetooth to a smartphone or directly to the cloud through WiFi for analysis. By applying proprietary algorithms and machine learning to this data, the system was intended to detect worsening patient conditions, potentially weeks before symptoms become noticeable. This data-driven approach allows clinicians to receive alerts and intervene with therapeutic adjustments, aiming to prevent hospital admissions and improve patient quality of life. The information was designed to be relayed directly into the caregiver's Electronic Medical Records (EMR) system, streamlining clinical workflows.
ReThink Medical's financial strategy involved a combination of grant funding and venture capital. The company was awarded two grants from the National Institutes of Health (NIH). In January 2017, it secured $3.22 million in a Series A funding round led by Emergent Medical Partners, with participation from Norwich Ventures and LaunchCapital. This financing was intended to support clinical trials and further development of its technology platform. The company also had a strategic partnership with the Japanese medical device corporation, Terumo. On August 11, 2020, ReThink Medical was acquired by Terumo.
Keywords: heart failure monitoring, medical device, digital health, CorBand, remote patient monitoring, predictive analytics, wearable sensor, continuous physiologic monitoring, cardiovascular disease, Terumo acquisition, Reza Naima, Emergent Medical Partners, preventing hospitalizations, ambulatory monitoring, EMR integration, data-driven healthcare, medical technology, cardiovascular health